Article

Study explores mechanism of increased nocturnal IOP

A study of the mechanisms involved in nocturnal changes in IOP indicates that a decrease in outflow facility is insufficient to compensate for a decrease in aqueous outflow. Episcleral venous pressure could be a factor in the circadian variations, however.

Key Points

Fort Lauderdale, FL-Recent research has indicated that IOP follows a circadian rhythm that includes a nocturnal increase, which occurs despite a nighttime decrease in aqueous humor flow. A new study offers some clues to understanding the complete mechanism of nocturnal IOP increases.

Researchers found that tonographically measured outflow facility does not decrease enough at night to compensate for the decrease in aqueous outflow but that episcleral venous pressure could be the cause of that change. It is also possible that multiple mechanisms are involved, said Arthur J. Sit, MD, who presented results of his research at the annual meeting of the Association for Research in Vision and Ophthalmology. He is assistant professor of ophthalmology, Mayo Clinic College of Medicine, Rochester, MN.

To investigate whether changes in outflow facility during the night could account for higher IOP, Dr. Sit conducted a study of the circadian variation of aqueous dynamics in adults. He recruited men and women, aged 18 to 45 years, from among the employees and students at the Mayo Clinic and the local community in Rochester.

The mid-diurnal protocol called for fluorophotometry and IOP measurement-sitting and supine-after 5 minutes, at 2 p.m., and again at 4 p.m. Additional tests at 4 p.m. included tonography followed by fluorescein drops. The subjects were awakened at 2 a.m. for the mid-nocturnal testing protocol, which included fluorophotometry and IOP measured sitting and supine. The same tests plus tonography were administered at 4 a.m.

All 68 eyes of 34 subjects were used in the analysis; 40 eyes were of patients aged 18 to 29 years (mean age, 23), and 28 eyes were of patients aged 30 to 45 years (mean age, 37). The clinical or baseline IOP was 13.2 mm Hg for all ages-12.8 mm Hg for the younger subgroup, and 13.6 mm Hg for the older subgroup.

Results presented

Results presented at ARVO meeting showed that sitting IOP decreased slightly from day to night. For all ages, mean daytime IOP was 13.8 mm Hg; for nighttime it was 12.9 mm Hg (p = 0.02). For patients aged 18 to 29, IOP dropped from 13.8 mm Hg to 13.1 mm Hg (p = 0.18), and for patients aged 30 to 45, pressure decreased from 13.9 mm Hg to 12.7 mm Hg (p = 0.05).

Supine IOP also decreased from the diurnal to the nocturnal interval. For all ages, the mean decline was from 18.9 mm Hg to 17.8 mm Hg (p = 0.001). For the younger subgroup, pressure dropped from 18.7 mm Hg to 17.6 mm Hg (p = 0.03); for older subjects, it declined from 19.2 mm Hg to 18.0 mm Hg (p = 0.006). When the sitting and supine IOPs were considered together, a marked increase in nocturnal IOP was evident when measured in the physiologic positions of sitting while awake and supine while asleep.

A highly statistically significant decrease in aqueous flow rate was observed, which declined by about 50% from day to night, Dr. Sit said. For all ages, it decreased from 2.26 to 1.12 μl/min (p < 0.001). For the 18-to-29-year subgroup, it declined from 2.21 to 1.08 μl/min, and for those subjects aged 30 to 45, it declined from 2.33 to 1.18 μl/min (both, p < 0.001).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.